Reducing Antibacterial Development Risk for GSK1322322 by Exploring Potential Human Dose Regimens in Nonclinical Efficacy Studies Using Immunocompetent Rats

Jennifer L. Hoover, Christine M. Singley, Philippa Elefante, Peter DeMarsh, Magdalena Zalacain, Stephen Rittenhouse
  • Antimicrobial Agents and Chemotherapy, August 2017, ASM Journals
  • DOI: 10.1128/aac.00959-17
The author haven't finished explaining this publicationThe author haven't finished explaining this publication

The following have contributed to this page: Ms Jennifer L Hoover

In partnership with: